title: Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
abstract: Fanconi anemia (FA) is a recessively inherited syndrome with predisposition to bone marrow failure and malignancies. Hypersensitivity to cross-linking agents is a cellular feature used to confirm the diagnosis. The mode of inheritance is autosomal recessive (12 subtypes) as well as X-linked (one subtype). Most genetic subtypes have initially been defined as "complementation groups" by cell fusion studies. Here we report a comprehensive genetic subtyping approach for FA that is primarily based on mutation screening, supplemented by protein expression analysis and by functional assays to test for pathogenicity of unclassified variants. Of 80 FA cases analyzed, 73 (91%) were successfully subtyped. In total, 92 distinct mutations were detected, of which 56 were novel (40 in FANCA, eight in FANCC, two in FANCD1, three in FANCE, one in FANCF, and three in FANCG). All known complementation groups were represented, except D2, J, L, and M. Three patients could not be classified because proliferating cell cultures from the probands were lacking. In cell lines from the remaining four patients, immunoblotting was used to determine their capacity to monoubiquitinate FANCD2. In one case FANCD2 monoubiquitination was normal, indicating a defect downstream. In the remaining three cases monoubiquitination was not detectable, indicating a defect upstream. In the latter four patients, pathogenic mutations in a known FA gene may have been missed, or these patients might represent novel genetic subtypes. We conclude that direct mutation screening allows a molecular diagnosis of FA in the vast majority of patients, even in cases where growing cells from affected individuals are unavailable. Proliferating cell lines are required in a minority (<15%) of the patients, to allow testing for FANCD2 ubiquitination status and sequencing of FANCD2 using cDNA, to avoid interference from pseudogenes.
authors.affiliation: Department of Clinical Genetics, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
authors.forename: Najim
authors.initials: N
authors.lastname: Ameziane
authors.forename: Abdellatif
authors.initials: A
authors.lastname: Errami
authors.forename: France
authors.initials: F
authors.lastname: Léveillé
authors.forename: Chantal
authors.initials: C
authors.lastname: Fontaine
authors.forename: Yne
authors.initials: Y
authors.lastname: de Vries
authors.forename: Rosalina M L
authors.initials: RM
authors.lastname: van Spaendonk
authors.forename: Johan P
authors.initials: JP
authors.lastname: de Winter
authors.forename: Gerard
authors.initials: G
authors.lastname: Pals
authors.forename: Hans
authors.initials: H
authors.lastname: Joenje
mesh_terms: D004252:DNA Mutational Analysis / Q000379:methods*; D005199:Fanconi Anemia / Q000175:diagnosis* / Q000235:genetics; D051856:Fanconi Anemia Complementation Group Proteins / Q000145:classification / Q000235:genetics*; D005816:Genetic Complementation Test; D005820:Genetic Testing; D006801:Humans; D008954:Models, Biological; D008957:Models, Genetic; D009154:Mutation
chemical_list: D051856:Fanconi Anemia Complementation Group Proteins